previous compound ID: 280 next compound
InChIKey: BTCSSZJGUNDROE-UHFFFAOYSA-N
SMILES: C(CC(=O)O)CN

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "E Matthes" "R Robert" "GW Carlile" "B Kus" "JW Hanrahan" "SD Macknight" "J Goepp" "J Liao" "D Rotin"

chemical graph of compound 280





CID is 119
synonyms found at PubChem are:
4-aminobutyric acid, 4-Aminobutanoic acid, GABA, gamma-aminobutyric acid, 56-12-2, Piperidic acid, Piperidinic acid, Aminalon, Gaballon, Gammalon, Mielogen, butanoic acid, 4-amino-, Gammalone, Mielomade, Gamarex, Gammasol, Gammar, Reanal, gamma-amino-n-butyric acid, Immu-G, gamma-Aminobutanoic acid, Butyric acid, 4-amino-, Gamastan, Gammagee, Gamulin, 4-aminobutyrate, omega-Aminobutyric acid, .gamma.-Aminobutyric acid, 3-Carboxypropylamine, 4-aminobutanoate, gamma-Aminobuttersaeure, 4-amino-butanoic acid, gamma-Amino butyric acid, gamma-aminobutyrate, 4-amino butyric acid, 4-Amino-butyric acid, DF 468, gamma Aminobutyric acid, CCRIS 3721, GAMMA-AMINO-BUTANOIC ACID, UNII-2ACZ6IPC6I, Aminobutanoic acid, NSC 27418, 4Abu, EPA Pesticide Chemical Code 030802, Gamma-aminobutyric acid [JAN], gamma-Aminobuttersaeure [German], AI3-26812, gamma-Aminobutryic acid, GAMMA(AMINO)-BUTYRIC ACID, 4-amino-n-butyric acid, 4-NH2-but, 4-NH3-but, Acide amino-4- butyrique [French], CHEMBL96, EINECS 200-258-6, 2ACZ6IPC6I, .gamma.-Aminobutanoic acid, [3H]GABA, MLS000028505, gamma-Aminobutyric acid (JAN), CHEBI:16865, BTCSSZJGUNDROE-UHFFFAOYSA-N, Butanoic acid, 4-amino- (9CI), NSC27418, NSC32044, NSC45460, NSC51295, 4-Aminobutylate, Butyric acid, 4-amino- (7CI,8CI), NCGC00015043-07, Aminalone, SMR000058285, 4-AMINO-BUTYRATE, WLN: Z3VQ, 20-79-1, BUTANOIC ACID,4-AMINO, g-Aminobutyric acid, Chemical Name: .gamma.-Aminobutanoic acid, SR-01000075618, Acide amino-4- butyrique, Immuglobin, Piperidinate, w-Aminobutyrate, 4-Aminobutyric, Gamma aminobutyrate, omega-Aminobutyrate, Gammalon (TN), a-Aminobutyric acid, w-Aminobutyric acid, gamma-Aminobuttersaure, gam.-Aminobutyric acid, Spectrum_000049, Tocris-0344, Aminobutyric acid,-4-, Butanoicacid, 4-amino-, Opera_ID_1152, Spectrum2_001208, Spectrum3_001385, Spectrum4_000809, Spectrum5_001425, Lopac-A-2129, Vigabatrin EP Impurity D, .omega.-Aminobutyric acid, cid_119, ACMC-1CAQ1, Biomol-NT_000230, bmse000340, bmse000820, bmse000871, D0C9XA, D0D3ID, .gamma.-Amino-butyric acid, AC1L18IR, AC1Q54DP, SCHEMBL4878, DSSTox_CID_15106, DSSTox_RID_79238, DSSTox_GSID_35106, Globulin, immune human serum, Lopac0_000005, Oprea1_584567, BSPBio_002970, Gamma-Aminobutyric Acid,(S), KBioGR_001297, KBioSS_000429, KSC269S7N, ARONIS27190, DivK1c_000616, NH2-(CH2)3-COOH, SPECTRUM1500678, .gamma.-Amino-N-butyric acid, SPBio_000996, GTPL1067, GTPL5410, SGCUT00121, DTXSID6035106, 5959-35-3 (hydrochloride), BDBM24183, CTK1G9976, HMS501O18, KBio1_000616, KBio2_000429, KBio2_002997, KBio2_005565, KBio3_002190, gamma-Aminobutyric acid, >=99%, MolPort-000-146-216, NINDS_000616, HMS1921C06, HMS2232P09, HMS3260A11, Pharmakon1600-01500678, DL-gamma-AMINO-n-BUTYRIC ACID, GABA (4-Amino-n-butyric acid ), STR01523, to_000021, ZINC1532620, 4-amino-n-[2,3-3H]butyric acid, Tox21_110071, Tox21_500005, 4-Aminobutyric acid, 97% 100g, ANW-13573, BBL008590, CCG-38515, GSK683699, LMFA01100039, MFCD00008226, NSC-27418, NSC-32044, NSC-45460, NSC-51295, NSC757426, PDSP1_001275, PDSP2_001259, s4700, SBB028179, STK301748, AKOS000119660, CS-W020704, DB02530, KS-5273, LP00005, MCULE-7613134021, NSC-757426, RP18806, RTR-019733, TRA0094659, CAS-56-12-2, IDI1_000616, KS-000048O9, 6610-05-5 (mono-hydrochloride salt), NCGC00015043-01, NCGC00015043-02, NCGC00015043-03, NCGC00015043-04, NCGC00015043-05, NCGC00015043-06, NCGC00015043-08, NCGC00015043-09, NCGC00015043-10, NCGC00024546-01, NCGC00024546-02, NCGC00024546-03, NCGC00024546-04, NCGC00024546-05, NCGC00024546-06, NCGC00260690-01, AJ-26795, AN-24434, BC204189, BP-21452, BR-43987, KB-62456, LS-47805, SC-10045, TL806167, gamma-Aminobutyric acid, BioXtra, >=99%, SBI-0049994.P003, AB1003088, gamma-Aminobutyric acid, analytical standard, ST2411110, TL8006100, TR-019733, 70582-09-1 (calcium salt (2:1)), A0282, AM20100372, EU-0100005, FT-0617569, ST45061580, A 2129, C00334, D00058, M-7233, 13511-EP2269989A1, 13511-EP2272537A2, 13511-EP2275401A1, 13511-EP2292222A1, 13511-EP2298766A1, 13511-EP2298776A1, 13511-EP2308875A1, 13511-EP2314571A2, 13511-EP2316836A1, 33777-EP2286811A1, 33777-EP2295055A2, 33777-EP2311453A1, AB00052155_12, 178648-EP2269992A1, 178648-EP2270002A1, 178648-EP2275102A1, 178648-EP2277865A1, L000262, I04-0182, I04-1117, SR-01000075618-1, SR-01000075618-3, SR-01000075618-6, SR-01000075618-7, BRD-K77245796-001-19-2, BUTANOIC ACID,4-AMINO 4-AMINO,BUTYRIC ACID, F2191-0196, Z955123658, C5C3DC27-C105-4D18-8A52-F51978B32D24, gamma-Aminobutyric acid, certified reference material, TraceCERT(R), InChI=1/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7, Vigabatrin impurity D, European Pharmacopoeia (EP) Reference Standard, gamma-Aminobutyric acid, United States Pharmacopeia (USP) Reference Standard, 3131-86-0, 4-ammoniobutanoate, 4-azaniumylbutanoate, 4euo, gamma-amino-N-butyrate, g-amino-n-butyric acid, 3ip9, D04QAC, CHEBI:59888, gamma-aminobutyric acid zwitterion, CJ-05261, A830919